ReviewDie Anaesthesiologie2025
[Amniotic fluid embolism].
Review in Die Anaesthesiologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Forensic evidence from a 30-year study of non-thrombotic pulmonary embolism.International journal of legal medicine · 2026Article
- PFO in pregnancy: amniotic fluid embolism complicated by paradoxical embolism.Clinical research in cardiology : official journal of the German Cardiac Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Amniotic fluid embolism is one of the leading causes of direct maternal deaths worldwide. It cannot be predicted. Pregnant women who have undergone a cesarean section, a multiple pregnancy, a placental implantation disorder, polyhydramnion, the need for drug-induced labor and a maternal age ≥ 35 years have a significantly increased risk of developing a peripartum amniotic fluid embolism. The diagnostics of amniotic fluid embolism are purely clinical and include a triad of sudden onset of hypoxia and hypotension, followed by coagulopathy. A causal treatment is not yet known. Treatment must be immediate and is symptom oriented. Decisive for the prognosis and the survival of the mother and neonate are the rapid diagnosis and immediate interdisciplinary treatment. When an amniotic fluid embolism is suspected more personnel must be commandeered without delay as many treatment steps must be carried out simultaneously.
Indexed as
Identifiers
40498141What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.